Using Kaplan-Meier analysis, we found that individuals with ApoE4 and chronic low-grade inflammation, defined as having a CRP cutoff level of 10 mg/L or more in at least 2 examinations, was more strongly associated with onset of dementia as well as AD compared with ApoE4 carriers without this level of inflammation. The gene discussed is CRP; the disease is Alzheimer disease.